Epstein Secrets

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <[email protected]> Subject: Nature article on ResearchGate! Date: Sat, 16 Aug 2014 16:09:26 +000

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <je

From: Boris Nikolic To: "Jeffrey Epstein ([email protected]

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <[email protected]> Subject: Nature article on ResearchGate! Date: Sat, 16 Aug 2014 16:09:26 +0000 ResearchGate is getting there! This week, the Nature (one of the competitors) published this article — esse

on of their employment relationship, bgC3 LLC ("Company"), on behalf of its Managers and the Individuals (as defined below in Section 2.1), and Dr. Boris Nikolic ("Dr. Nikolic"), a single person, agree as follows: RECITALS A. Company and Dr. Nikolic entered into an employment agreement regarding employment

nt relationship, bgC3 LLC ("Company"), on behalf of its Managers and the Individuals (as defined below in Section 2.1), and Dr. Boris Nikolic ("Dr. Nikolic"), a single person, agree as follows: RECITALS A. Company and Dr. Nikolic entered into an employment agreement regarding employment with Company

duals (as defined below in Section 2.1), and Dr. Boris Nikolic ("Dr. Nikolic"), a single person, agree a

request to purchase from [bgC3] (a) up to 30% of [bgC3]'s equity interests in Foundation Medicine and (b) up to 30% of [bgC3]'s equity interests in ResearchGate, in each case in cash at a price per share or unit equivalent to the original price per share or unit paid by [bgC3] (collectively, the "Investment

From: jeffrey E. <[email protected]> Sent: Saturday, August 16, 2014 8:50 PM To: Boris Nikolic Subject: Re: copy if you can have the same financail positon but not be subj=ct to the whim, his demise, or melinda interferring, the sooner the

terferring, the sooner the =etter. but onlyu after research gate annonces fundraisiong =div class="gmail_extra"> On Sat, Aug 16, 2014 at 12:54 PM, Boris =ikolic < > wrote: Not sure that it is worth=doing it. Not sure re tax implicati=ns. And I can't do it=right now as ResearchGate still did not st

t: Saturday, August 16, 2014 8:50 PM To: Boris Nikolic Subject: Re: copy if you can have the same fin

g 16, 2014 at 12:54 PM, Boris =ikolic < > wrote: Not sure that it is worth=doing it. Not sure re tax implicati=ns. And I can't do it=right now as ResearchGate still did not start fundrising (they are working=on a major strategic move which might even more inflate the valuation).=/u> If I will face a probl

From: Boris Nikolic < Sent: Saturday, August 16, 2014 8:52 PM To: jeffrey E. Subject: RE: copy Agree 100% B From: jeffrey E. [mailto:[email protected]) Sent: S

From: Boris Nikolic < Sent: Saturday, August 16, 2014 8:52 PM To:

From: Boris Nikolic < Sent: Saturday, August 16, 2014 8:52

g 16, 2014 at 12:54 PM, Boris Nikolic > wrote: Not sure that it is worth doing it. Not sure re tax implications. And I can't do it right now as ResearchGate still did not start fundrising (they are working on a major strategic move which might even more inflate the valuation). If I will face a problem w

From: Boris Nikolic < Sent: Saturday, August 16, 2014 4:55 PM To: Jeffrey E. Subject: RE: copy Not sure that it is worth doing it. Not sure re tax implications. And

From: Boris Nikolic < Sent: Saturday, August 16, 2014 4:55 PM To:

From: Boris Nikolic < Sent: Saturday, August 16, 2014 4:55

2014 4:55 PM To: Jeffrey E. Subject: RE: copy Not sure that it is worth doing it. Not sure re tax implications. And I can't do it right now as ResearchGate still did not start fundrising (they are working on a major strategic move which might even more inflate the valuation). If I will face a problem w

From: jeffrey E. <[email protected]> Sent: Saturday, August 16, 2014 5:37 PM To: Boris Nikolic Subject: Re: copy yes, this if for december On Sat, Aug 16, 2014 at 12:54 =M, Boris Nikolic > wrote: Not sure that it is worth=doing it. Not s

t: Saturday, August 16, 2014 5:37 PM To: Boris Nikolic Subject: Re: copy yes, this if for december O

> Sent: Saturday, August 16, 2014 5:37 PM To: Boris Nikolic Subject: Re: copy yes, this if for dec

Aug 16, 2014 at 12:54 =M, Boris Nikolic > wrote: Not sure that it is worth=doing it. Not sure re tax implicati=ns. And I can't do it=right now as ResearchGate still did not start fundrising (they are working=on a major strategic move which might even more inflate the valuation).=/u> If I will face a probl

reement Regarding Purchase of Partnership Interest This letter sets forth the agreement by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we disc

rchase of Partnership Interest This letter sets forth the agreement by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we discussed potentia

een you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purc

t (including all dividends, payments, distributions, securities and other items of value at any time previously or hereafter distributed or paid by ResearchGate in - 63 - EFTA_R1_00438149 EFTA01961337 3. respect of such investment) as of the date of such Investment Entity Payment Demand, less (b) Ten Mi

artnership Interest Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we dis

Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we discussed potenti

een you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purc

uch investment, together with any and all dividends, payments, distributions, securities or other items of value at any time distributed or paid by ResearchGate to the Gates Purchaser in respect of such investment shall be referred to herein as the "ResearchGate Investment"). At any time and from time to t

artnership Interest Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we dis

Effective September 3, 2013, this letter sets forth the "Agreement" by and between you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purchase by Gates from Dr. Nikolic of Dr. Nikolic's interest in a partnership, under the terms of which we discussed potenti

een you, William H. Gates ("Gates"), and me, Dr. Boris Nikolic ("Dr. Nikolic"), with respect to the purc

uch investment, together with any and all dividends, payments, distributions, securities or other items of value at any time distributed or paid by ResearchGate to the Gates Purchaser in respect of such investment shall be referred to herein as the "ResearchGate Investment"). At any time and from time to t

1990 and 1992 and subsequently joined the World Bank where he was involved in the development of the financial sector in Russia. Boris Nlkolk Dr. Boris Nikolic is a Chief Advisor for Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gat

Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities.

ceived his MD from Zagreb Medical School and his clinical training from the University's Medical Center, University of Zagreb, Croatia. In 1994, Dr. Nikolic joined the Harvard Graduate Program in Immunology. Subsequently, Boris continued to serve in roles of increasing authority including postdoctoral f

, Lilly Ventures and Schrodinger (9.5%). Research Gate ResearchCate is developing a social networking site for the research scientist community. At ResearchGate. more than 3.5 million researchers already share and curate their data and results. The site has been described as a mashup of -Facebook, Twitter a